Indian F&O data, and the evidence about what not to trade · educational
MAXHEALTH · Healthcare
1M / 3M / 1Y
-7.1% / -1.6% / -14.4%
Traded value (60d med)
₹184 cr
Days in F&O ban since 2020
0
Futures OI / 1d change
10.5M / -0.1M
ATM implied vol
23% (vs 25% realized)
📜 Results-day history
Typical move 1.5% · up on the day 52% of 23 events · moved 4%+ in 17% · worst -4.2% / best +6.0%
| Reaction day | Move | Open gap | Next 5d | Announced |
|---|
| 2026-04-30 | -1.3% | -7.1% | +2.2% | after close |
| 2026-01-30 | +0.4% | -0.8% | +8.7% | after close |
| 2025-10-30 | -0.9% | -0.3% | -4.5% | after close |
| 2025-07-28 | -1.8% | -0.4% | -0.6% | after close |
| 2025-04-30 | -0.8% | +1.6% | +1.2% | after close |
| 2025-01-30 | +1.8% | +1.5% | +7.8% | during mkt |
| 2024-11-06 | +3.4% | -0.2% | -7.2% | after close |
| 2024-08-01 | +0.2% | +1.4% | -5.3% | during mkt |
Educational data reference: NOT investment advice. Historical statistics do not predict future results. We are not SEBI-registered advisers. All data from NSE public sources; figures may contain errors. Trading, especially leveraged F&O, can cause significant losses.